SCHEMBL1926067

SCHEMBL1926067

CC(=O)C(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13113139 1.00
SCHEMBL13113138 1.00
Phosphoric Acid SCHEMBL6546747 0.89 OR51E2 (0.43)
Methacrylic Acid SCHEMBL9511444 0.84 OR51E2 (0.46)
SCHEMBL10599831 0.77 OR51E2 (0.43)
SCHEMBL6702996 0.77 LMNA (0.40)
SCHEMBL17378384 0.76 TET2 (0.35)
Acetic Acid SCHEMBL9450190 0.75 OR51E2 (0.82)
Acetone SCHEMBL2905545 0.75 OR51E2 (0.82)
Acetone SCHEMBL2903665 0.75 OR51E2 (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903386-A Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition 厦门碳控科技投资有限公司 2024-04-19 CN claimed
CN-108697301-A Portable decontamination external member 皇家飞利浦有限公司 2018-10-23 CN claimed
WO-2012092232-A2 A STRATEGY FOR ON-SITE IN SITU GENERATION OF OXIDIZING COMPOUNDS AND APPLICATION OF THE OXIDIZING COMPOUND FOR MICROBIAL CONTROL NALCO COMPANY (US) 2012-07-05 WO claimed
US-20120165407-A1 STRATEGY FOR ON-SITE IN SITU GENERATION OF OXIDIZING COMPOUNDS AND APPLICATION OF THE OXIDIZING COMPOUND FOR MICROBIAL CONTROL ECOLAB USA INC. 2012-06-28 US claimed
EP-0939632-B1 NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS LILLY CO ELI (US) 2005-10-05 EP claimed
US-6521611-B2 2-(azetidin-2-on-1-yl) acetic acid derivatives; treatment of obsessive-compulsive disorder ELI LILLY AND COMPANY 2003-02-18 US claimed
CN-1044547-C Biodegradable controlled release matrices GOODMAN FIELDER WATTIE AUSTRAL (AU) 1999-08-11 CN claimed
CN-1050122-A The matrix of biodegradable sustained release GOODMAN FIELDER WATTIE AUSTRAL (AU) 1991-03-27 CN claimed
CN-121825952-A 3, 4-Dihydroxyl-2-butanone-4-phosphate synthetase mutant and application thereof 天津大学 2026-04-10 CN disclosed
CN-121825952-A 3, 4-Dihydroxyl-2-butanone-4-phosphate synthetase mutant and application thereof 天津大学 2026-04-10 CN disclosed
US-20250369024-A1 Acyloin Condensation Reactions, Enzymes, and Products Thereof MOJIA BIOTECH PTE LTD (SG) 2025-12-04 US disclosed
US-20250076302-A1 DETECTING THE PRESENCE OF URINARY STONE DISEASE USING A PLURALITY OF URINARY METABOLITES THE CLEVELAND CLINIC FOUNDATION 2025-03-06 US disclosed
US-20240294951-A1 GLYCEROL FREE ETHANOL PRODUCTION DANISCO US INC (US) 2024-09-05 US disclosed
CN-118460590-A Method for regulating and controlling high-yield hydroxytyrosol of saccharomyces cerevisiae by reverse metabolic engineering based on metabonomics technology 江南大学 2024-08-09 CN disclosed
WO-1999027126-A1 ribG SMITHKLINE BEECHAM CORPORATION (US) 1999-06-03 WO disclosed
WO-1999027125-A1 ribA SMITHKLINE BEECHAM CORPORATION (US) 1999-06-03 WO disclosed
WO-1999027127-A1 NOVEL ribB SMITHKLINE BEECHAM CORPORATION (US) 1999-06-03 WO disclosed
US-5891672-A UTILIZING RIBA POLYPEPTIDES TO SCREEN FOR ANTIBACTERIAL COMPOUNDS. SMITHKLINE BEECHAM CORPORATION (US) 1999-04-06 US disclosed
WO-1997030707-A1 NON-PEPTIDYL VASOPRESSIN V1a ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-08-28 WO disclosed
US-5380540-A Adding salt, monomer or polymer of triose-reductone, hydroxymalondialdehyde or hydroxypyruvaldehyde TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-01-10 US disclosed